Financhill
Sell
28

RVPH Quote, Financials, Valuation and Earnings

Last price:
$1.64
Seasonality move :
-10.48%
Day range:
$1.23 - $1.51
52-week range:
$0.60 - $5.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
4.4M
Avg. volume:
3.4M
1-year change:
-63.62%
Market cap:
$44.6M
Revenue:
--
EPS (TTM):
-$1.09

Earnings Data

Next earnings date for RVPH
Apr 15
2025
Most recent earnings per share
-$0.25
Missed by --
(Nov 14/2024)
Consensus Estimate
-$0.25
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RVPH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 -- -- -- -$0.22 --
11/14/2024 Q3 -- -- -$0.25 -$0.25 --
08/14/2024 Q2 -- -- -$0.26 -$0.31 $0.05
05/14/2024 Q1 -- -- -$0.25 -$0.38 $0.13
03/29/2024 Q4 -- -- -$0.33 -$0.37 $0.04
11/14/2023 Q3 -- -- -$0.44 -$0.39 -$0.05
08/14/2023 Q2 -- -- -$0.52 -$0.25 -$0.27
05/15/2023 Q1 -- -- -$0.31 -$0.29 -$0.02
03/30/2023 Q4 -- -- -$0.58 -$0.23 -$0.35
11/14/2022 Q3 -- -- -$0.18 -$0.26 $0.08
08/15/2022 Q2 -- -- -$0.29 -- --
03/31/2022 Q1 -- -- -$0.40 -- --
12/31/2021 Q4 -- -- -$0.22 -- --
11/15/2021 Q3 -- -- -$0.12 -- --
08/16/2021 Q2 -- -- -$0.12 -- --
05/17/2021 Q1 -- -- -$0.10 -- --
12/31/2020 Q4 -- -- -$0.42 -- --
01/14/2021 Q4 -- -- -$0.04 -- --
09/30/2020 Q3 -- -- -$0.24 -- --
06/30/2020 Q2 -- -- -$0.31 -- --
03/31/2020 Q1 -- -- -$0.27 -- --

Reviva Pharmaceuticals Holdings Earnings Questions

  • How Much did Reviva Pharmaceuticals Holdings Generate in Revenue Last Quarter?

    Reviva Pharmaceuticals Holdings reported -- worth of top line sales in its most recent quarter.

  • Did Reviva Pharmaceuticals Holdings Beat Earnings Last Quarter?

    Reviva Pharmaceuticals Holdings announced earnings per share of -$0.25 which represents a miss of analyst forecast a -$0.25 per share.

  • Is Reviva Pharmaceuticals Holdings Profitable?

    Reviva Pharmaceuticals Holdings reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Reviva Pharmaceuticals Holdings EPS Next Year?

    Reviva Pharmaceuticals Holdings's earnings are forecast to decrease from -$1.65 per share to -$1.66 per share next year representing a decrease of -39.7%.

  • When is Reviva Pharmaceuticals Holdings's Earnings Date?

    Reviva Pharmaceuticals Holdings's next earnings date is April 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 3.65% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 4.9% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock